Logotype for The Clorox Company

The Clorox Company (CLX) Proxy filing summary

Event summary combining transcript, slides, and related documents.

Logotype for The Clorox Company

Proxy filing summary

7 Oct, 2026

Executive summary

  • FY26 transition year: completed U.S. ERP implementation, acquired GOJO and acquired full ownership of the Glad bags and wraps business; FY27 priorities include profitable growth, innovation and margin recovery.

  • Net sales were $6.7B, down 5% YoY; net earnings attributable to Clorox were $587M, down 28%, and gross margin was 42.3%, down 290 bps.

  • Linda Rendle requested a CEO search for health reasons; she remains Chair and CEO until a successor is appointed and will serve in an advisory role afterward.

Voting matters and shareholder proposals

  • Annual meeting set for November 18, 2026, virtually; agenda: elect 10 directors, approve executive compensation on an advisory basis and ratify Ernst & Young LLP for FY27.

  • Board recommends FOR all 10 nominees, say-on-pay and auditor ratification; 2025 say-on-pay received ~91% of votes cast in favor.

  • Director elections require a majority of votes cast; proposals 2 and 3 require a majority of voting power present and entitled to vote. Abstentions count against proposals 2 and 3.

  • Rule 14a-8 proposals for the 2027 meeting are due June 9, 2027; proxy-access notices are due May 10–June 9, 2027, subject to eligibility requirements.

Board of directors and corporate governance

  • Ten nominees stand for election through the 2027 annual meeting; A.D. David Mackay will not seek re-election, reducing the Board from 11 to 10 directors.

  • Nine of 10 nominees are independent; average nominee tenure is 6.3 years, and five new independent directors joined since 2022.

  • Independent CEO Search Committee, chaired by Lead Independent Director Matthew Shattock and including the three independent committee chairs, leads the CEO search and reports regularly to the full Board.

  • In FY27, an independent third-party facilitator is planned for annual Board, committee and director evaluations.

  • Board structure combines Chair and CEO with a strong lead independent director and independent committee chairs; all standing committees consist solely of independent directors.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more

Latest events from The Clorox Company